OSRX Expands Ophthalmic Solutions with New Medications and Post-Op Kits to Patients’ Doors

Audio By Carbonatix

MISSOULA, Mont.--(BUSINESS WIRE)--Mar 17, 2025--

OSRX, a leader in ophthalmic compounding, introduces new medications and direct-to-patient post-op kits designed to streamline workflows and enhance the patient experience. Whether optimizing medication management or eliminating post-op supply headaches, OSRX delivers innovative solutions for ophthalmologists and optometrists nationwide.

Say Hello to Dilation, Simplified: Tropicamide 1% + Phenylephrine 2.5% (10mL)

OSRX now offers Tropicamide 1% + Phenylephrine 2.5% * in a 10mL fill, in addition to 2mL. This larger size provides better value, helping practices cut down on reorders while ensuring quality care for patients.

• Available for individual prescriptions or bulk orders.**
• Streamlines the dilation process with every drop.
• Reduces medication waste while ensuring access.

“When I started prescribing OSRX’s Tropicamide/Phenylephrine HCl dilation drops over two years ago, our patient process completely transformed. The medications provide our patients with what they need, and as an added benefit, using OSRX has streamlined our procedures, enabling us to focus even more on what we do best: providing exceptional patient care.”
— Paul Mann, MD, Mann Eye Institute

Brimonidine 0.1% + Dorzolamide 2% Now in a Larger 5mL Fill Volume for Greater Efficiency

The expanded 5mL option ofBrimonidine 0.1% + Dorzolamide 2% * delivers greater convenience for prescribers while keeping costs in check for patients.

• Optimized for combination therapy management.

• Available for direct-to-patient shipping or office stock.**
• Flexible and convenient for long-term care.

"OSRX goes the extra mile to provide a quality, customized product that’s also affordable for my patients."
— Preeya Gupta, MD, Triangle Eye Consultants

Post-Op Kits Delivered Directly to Patients – Now Available!

OSRX partners with a third-party manufacturer to offer exclusive direct-to-patient post-op kits, reducing logistical burdens on practices.

Each kit includes:

• Premium, durable post-op bag
• Solar Shield sunglasses
• Polycarbonate eye shield and tape

OSRX remains dedicated to simplifying ophthalmic care with quality, affordable and patient-focused solutions. Get a custom quote today at osrxpharmaceuticals.com/pricing.

About OSRX:

OSRX is an FDA-registered 503B outsourcing facility transforming ophthalmic care through quality compounded solutions. Based in Missoula, MT, OSRX is redefining corrective eye care with a focus on simplicity, affordability, and patient care. Trusted by over 7,300 prescribers across the U.S., OSRX is providing A New View of Medicine®. Learn more at www.osrxpharmaceuticals.com.

** Select states pending.

*Tropicamide/Phenylephrine and Brimonidine Tartrate/Dorzolamide carry serious risks, including transient stinging and burning on instillation, temporary blurred vision and photophobia. View all potential adverse events and contraindications at: www.osrxpharmaceuticals.com/osrx-api-aecontraindication.

For professional use only. OSRX specializes in customizing compounded medications to meet patient needs as prescribed by their practitioners. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.

Professional Disclosure: Drs. Mann and Gupta are on the Medical Advisory Board for Ocular Science® (an affiliate of OSRX) and have a financial interest in the company.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250317365273/en/

CONTACT: Media Contact:

Vanessa Assam-Gorski, OSRX Marketing Manager – (541) 944-8531; [email protected]

KEYWORD: UNITED STATES NORTH AMERICA MONTANA

INDUSTRY KEYWORD: SURGERY MEDICAL DEVICES HEALTH PHARMACEUTICAL OPTICAL

SOURCE: OSRX

Copyright Business Wire 2025.

PUB: 03/17/2025 05:59 PM/DISC: 03/17/2025 05:58 PM

http://www.businesswire.com/news/home/20250317365273/en